Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study

BACKGROUND: The virological and immunological effects of the immunomodulatory drugs used for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and the antibody response in patients with COVID-19. METHODS: Prospective cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Masiá, Mar, Fernández-González, Marta, Padilla, Sergio, Ortega, Piedad, García, José A., Agulló, Vanesa, García-Abellán, Javier, Telenti, Guillermo, Guillén, Lucía, Gutiérrez, Félix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492814/
https://www.ncbi.nlm.nih.gov/pubmed/32950003
http://dx.doi.org/10.1016/j.ebiom.2020.102999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492814/
https://www.ncbi.nlm.nih.gov/pubmed/32950003
http://dx.doi.org/10.1016/j.ebiom.2020.102999

Ejemplares similares